BRAF and colorectal carcinoma: In CRC with MSI-H or dMMR, BRAF V600E mutations are often accompanied by MLH1 expression deficiency or MLH1 gene promoter region hypermethylation, with a concomitant rate of about 30%–75% reported abroad (Ward et al., 2013).